These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15541220)

  • 1. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
    Arora A; Moeller L; Froeschle J
    J Travel Med; 2004; 11(4):195-9. PubMed ID: 15541220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine.
    Jones RL; Froeschle JE; Atmar RL; Matthews JS; Sanders R; Pardalos J; Moeller L; Chin JE; Famula M; Briggs DJ; Lang J
    Vaccine; 2001 Sep; 19(32):4635-43. PubMed ID: 11535311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children.
    Sabchareon A; Lang J; Attanath P; Sirivichayakul C; Pengsaa K; Le Mener V; Chantavanich P; Prarinyanuphab V; Pojjaroen-Anant C; Nimnual S; Wood SC; Riffard P
    Clin Infect Dis; 1999 Jul; 29(1):141-9. PubMed ID: 10433577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
    Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
    Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
    Quiambao BP; Lang J; Vital S; Montalban CG; Le Mener V; Wood SC; Miranda E
    Acta Trop; 2000 Feb; 75(1):39-52. PubMed ID: 10708006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
    Soentjens P; Andries P; Aerssens A; Tsoumanis A; Ravinetto R; Heuninckx W; van Loen H; Brochier B; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Feb; 68(4):607-614. PubMed ID: 29939243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
    Pineda-Peña AC; Jiang Q; Petit C; Korejwo-Peyramond J; Donazzolo Y; Latreille M; Homery MC; Babin V; Benamor S; Pichon S; Guinet-Morlot F; Minutello AM
    Clin Infect Dis; 2024 Jun; 78(6):1748-1756. PubMed ID: 38478634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination.
    Bernard KW; Mallonee J; Wright JC; Reid FL; Makintubee S; Parker RA; Dwyer DM; Winkler WG
    JAMA; 1987 Feb; 257(8):1059-63. PubMed ID: 3806894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P; Lazzaro M; Darioli R
    Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to achieve predicted antibody responses with intradermal and intramuscular human diploid cell rabies vaccine.
    Lemon SM; Miller RN; Pang LW; Prier RE; Bernard KW
    Lancet; 1984 May; 1(8386):1098-100. PubMed ID: 6144829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
    Yu P; Yan J; Wu W; Tao X; Lu X; Liu S; Zhu W
    Virol J; 2018 Nov; 15(1):174. PubMed ID: 30424815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial.
    Zhou X; Wu X; Cai Y; Cao S; Zhu X; Lv Q; Chen H; Shi L; Li J; Wang X; Li Y; Zhou R
    Hum Vaccin Immunother; 2019; 15(4):828-833. PubMed ID: 30457436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children.
    Angsuwatcharakon P; Khomvilai S; Limsuwun K; Ratananpinit N; Khamchat A; Sanitnai T; Tantawichien T
    Expert Rev Vaccines; 2018 Feb; 17(2):185-188. PubMed ID: 29285961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
    Pichon S; Moureau A; Petit C; Kirstein JL; Sheldon E; Guinet-Morlot F; Minutello AM
    Vaccine; 2024 Apr; 42(10):2553-2559. PubMed ID: 38105138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations.
    Fishbein DB; Dreesen DW; Holmes DF; Pacer RE; Ley AB; Yager PA; Sumner JW; Reid-Sanden FL; Sanderlin DW; Tong TC
    Vaccine; 1989 Oct; 7(5):437-42. PubMed ID: 2815979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.